tirzepatide vs semaglutide compound vs. for Weight Loss Elevate Health GLP-1 Program Analysis:

4.7 SURPASS J-mono trial in Japan In Japan, the SURPASS J-mono trial enrolled 636 Japanese adults with type 2 diabetes (age 20 years) who discontinued oral monotherapy or were treatment-naive due to hyperglycemia (Yabe et al., 2023)

After tirzepatide was approved for marketing in the United States in 2022, the number of prescriptions has continued to grow rapidly, and the growth rate far exceeds that of semaglutide during the same period, driving the rapid increase of tirzepatide's market share

The weight loss difference between liraglutide and phentermine is smaller than with semaglutide or tirzepatide, which means the other factors, cost, side effects, duration of treatment, and long-term outcomes, carry more relative weight in the decision

Recognizing Injection Depth Errors: While the tirzepatide pen is designed to deliver medication to the correct depth when used properly, errors can still occur

Telemedicine allows us to provide consistent, high-quality care wherever you live in the Denver metro area